REVB (revbiosciences.com) Bozor qiymatining balans qiymatiga nisbati
Revelation Biosciences hozirda ilmiy tadqiqotlarga e'tibor qaratgan, bunda yuqori laboratoriya xarajatlari tijoratlashtirilgunga qadar foyda o'sishini cheklamoqda. Ushbu bozor qiymatining bukhgalteriya qiymatiga nisbati grafigi aktivlarning joriy qiymatini vizuallashtiradi, bunda 0.21 qiymati metrika darajasini aks ettiradi. REVB moliyaviy barqarorligi test natijalariga bog'liq, immunoterapiya sohasidagi strategik sherikliklar esa startapning investitsiya jozibadorligini oshiradi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_REVB_-_Revelation-Biosciences_-_Market-Capitalization-to-Net-Assets "REVB Revelation Biosciences Corp Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Revelation Biosciences Inc (REVB) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Revelation Biosciences|REVB - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Revelation Bio|REVB - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Revelation Bio|REVB - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Revelation Biosciences
Kompaniyaning dastlabki tahlili:Revelation Biosciences - REVB
Ushbu koeffitsient biznesning bozor qiymatini uning sof aktivlariga solishtirib, kelajakdagi o'sish uchun qo'shimcha qiymatni o'lchaydi. Bu investorga kapitalning haqiqiy baholanishidan spekulyativ shovqinlarni ajratib olishga yordam beradi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbatini tahlil qilish orqali, boshqaruv strategiyasiga bo'lgan bozor ishonchini baholash mumkin. Revelation Biosciences (REVB) uchun ushbu ko'rsatkich REVTx-300 dori vositasining buyraklarni himoya qilish salohiyatini aks ettiradi. Ushbu jarrohlik yechimining noyobligi yuqori bozor premiumini oqlaydi.
Asosiy raqobatchilar
argenx SE (ARGX) - Bozor kapitallashuvining balans qiymatiga nisbati|BNTX (biontech.de) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Savara Inc - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Rigel Pharmaceuticals Inc (RIGL)|ANAB - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ATXS|Bozor qiymatining balans qiymatiga koeffitsiyenti engene.com|Kapitallashuvning sof aktivlarga nisbati RAPT Therapeutics|Bozor qiymatining balans qiymatiga nisbati Aerovate|Aclaris - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti KYTX (Kyverna Therapeutics, Inc)|Bozor qiymatining balans qiymatiga nisbati Tiziana Life Sciences TLSA|Bozor qiymatining balans qiymatiga nisbati cabalettabio.com CABA|Ventyx Biosciences, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Theratechnologies, Inc. (THTX) - Bozor kapitallashuvining balans qiymatiga nisbati|AVTX - Kapitallashuvning sof aktivlarga nisbati|Eledon Pharmaceuticals, Inc (ELDN) - Bozor kapitallashuvining balans qiymatiga multiplikatori|AGEN: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CLYM|Zura Bio - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ATYR (aTyr Pharma Inc)|ADAG - Bozor qiymatining balans qiymatiga nisbati|IMA - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Shattuck Therapeutics (STTK)|EQ - Balans qiymatiga nisbatan bozor qiymati|connectbiopharm.com (CNTB) - Bozor kapitallashuvining balans qiymatiga nisbati|Immunic (IMUX) - Bozor qiymatining balans qiymatiga nisbati|ATRA: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi IFRX|X4 Pharmaceuticals - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ACET (adicetbio.com)|Bozor qiymatining balans qiymatiga nisbati CELU|Balans qiymatiga nisbatan bozor kapitallashuvi INmune Bio Inc INMB|BRNS: Bozor kapitallashuvining balans qiymatiga nisbati|KZR - Kapitallashuvning sof aktivlarga nisbati|SAB Biotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|akaritx.com (AKTX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ENLV (Enlivex Therapeutics Ltd)|Bozor qiymatining balans qiymatiga koeffitsiyenti QTTB|Bozor qiymatining balans qiymatiga nisbati GeoVax Labs Inc GOVX|Kapitallashuvning balans qiymatiga nisbati Edesa Biotech Corp (EDSA)|iBio, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Carisma Therapeutics Inc CARM|XTLB (XTL Biopharmaceuticals Ltd.) - Bozor kapitallashuvining balans qiymatiga nisbati|BOLT: Bozor qiymatining balans qiymatiga koeffitsiyenti|hcwbiologics.com - Bozor qiymatining balans qiymatiga nisbati|APVO (Aptevo Therapeutics Inc.) - Balans qiymatiga nisbatan bozor kapitallashuvi|AIM - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Aditxt Corp|GRI Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti XORTX Therapeutics Inc XRTX|Kapitallashuvning sof aktivlarga nisbati ReShape Lifesciences HIND|Bozor qiymatining balans qiymatiga nisbati Indaptus Corp INDP|SCNI - Bozor kapitallashuvining balans qiymatiga nisbati|CALI: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati affimed.com (AFMD)|Allakos (ALLK) - Sof aktivlarga nisbatan bozor kapitallashuvi|HOOK - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati IGM Bio|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|Bozor kapitallashuvining balans qiymatiga nisbati OCEA (oceanbiomedical.com)|Bozor qiymatining balans qiymatiga nisbati TC BioPharm|Third Harmonic Bio Inc. - Balans qiymatiga nisbatan bozor qiymati